Logo

Bafna Pharmaceuticals Ltd. Share Price

Pharmaceuticals & Drugs

Bafna Pharmaceuticals Ltd. (INR)74.840   (0%)

Exchange ScripsBSE532989NSEBAFNAPHISININE878I01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Bafna Pharmaceuticals Ltd. Performance

Market performance

Open price77.58
High77.59
Volumes1888
Prev Close74.84
Low73.1
Closing date2025-04-17

Historical performance

1 Year High113.00
3 Year High140.00
5 Year High233.55
1 Year Low69.00
3 Year Low69.00
5 Year Low20.35

Bafna Pharmaceuticals Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
177
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-8.16
Dividend Yield
Dividend Yield
N/A

Bafna Pharmaceuticals Ltd. Investment Returns

1 Year
-14%
3 Years
-42.6%
5 Years
285.8%
10 Years
149.5%

Bafna Pharmaceuticals Ltd. Technicals

IndicatorsValueSignal
5-DMA73.92Bullish
10-DMA74Bullish
20-DMA76.48Bearish
50-DMA76.88Bearish
100-DMA78.84Bearish
200-DMA80.71Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors71357207728873847532
Government---------------

Bafna Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2020Mar-2019Mar-2018Mar-2017
Other Income3431311
Operating Profit15-127-38-47
Interest12169115
Depreciation33354042
Profit Before Tax-19-183-147-204
Consolidated Net Profit-247-189-167-191
Adjusted EPS-9-8-7-10

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2020Mar-2019Mar-2018Mar-2017
Share Capital24237237187
Total Reserves-66-46143200
Minority Interest1-2-7-6
Total Non-Current Liabilities30298413547
Total Liabilities713119513841783
Capital Work in Progress2---------
Total Assets713119513841783

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2020Mar-2019Mar-2018Mar-2017
Cash Flow from Operating Activities-343-18-70-9
Cash Flow from Investing Activities328154380-54
Cash Flow from Financing Activitie73-138-30663
Net Cash Inflow / Outflow58-23-1
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -8.16.
  • 3Y Stock Price CAGR of the stock is -18.4.
  • The stock has a beta of 0.3.
  • In the last financial year, the company had an EBITDA of ₹15 Million.
  • The company generated revenue of ₹425 Million in the previous financial year.

Bafna Pharmaceuticals Ltd.

74.840   (0%)

Investment Amount: ₹ 1000000
Current Value: ₹ 877374
No. of Shares: 11723.3
Performance:-12.3%
P/L: ₹-122626

Top Gainers

SymbolChange%
SECMARK124.29(20%)
OSWALGREEN43.33(18%)
FACT760.85(14%)
OSWALAGRO96.73(13%)
SMSLIFE1435.2(13%)

Top Losers

SymbolChange%
VIKASLIFE2.59(-9%)
ROML50.49(-7%)
SONATSOFTW314.7(-6%)
ROSSELLIND77.66(-6%)
DYNPRO291(-6%)
TREJHARA232.28(-6%)
GATECHDVR1.05(-5%)
MGEL14.23(-5%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

65.8

56.06

March 20 - April 20

Brooks Laboratories Ltd.

41.3

139.77

March 20 - April 20

SMS Lifesciences India Ltd.

37.2

1435.2

March 20 - April 20

Panacea Biotec Ltd.

33.5

522.95

March 20 - April 20

Bal Pharma Ltd.

28.9

104.91

March 20 - April 20

Kopran Ltd.

27.8

202.58

March 20 - April 20

Wanbury Ltd.

27.2

263.47

March 20 - April 20

Hester Biosciences Ltd.

24.5

1774.9

March 20 - April 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month